"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about ZETIA
• Ask Community about ZETIA
• ZETIA Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

ZETIA Safety Questions, ZETIA Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about ZETIA. Our extensive database of ZETIA adverse events and ZETIA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about ZETIA

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

ZETIA Safety Reports

Total ZETIA reports: 500.
ZETIA FDA safety alerts: No.
Reported deaths: 13    Reported hospitalizations: 247.
Take ZETIA Side Effects Survey or Share Your ZETIA Story. ZETIA Usage.

Showing 1-75 of 500 Next >

Consumer or non-health professional from UNITED STATES reported ZETIA problem on Mar 20, 2007. Female patient, 70 years of age, was diagnosed with blood cholesterol, procedural pain and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: arthropathy, myalgia. ZETIA dosage: unknown. During the same period patient was treated with OXYCODONE. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Mar 27, 2007. Male patient, 66 years of age, was diagnosed with hyperlipidaemia, convulsion, hypertension and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: convulsion. ZETIA dosage: unknown. During the same period patient was treated with DILANTIN, KEPPRA. Patient recovered.

Consumer or non-health professional from ITALY reported ZETIA problem on Mar 05, 2007. Female patient, 16 years of age, weighting 136.0 lb, was diagnosed with type iia hyperlipidaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood thyroid stimulating hormone increased, varicella. ZETIA dosage: 10 MG/DAILY/PO. During the same period patient was treated with ZOCOR. Patient recovered.

ZETIA problem was reported by a Pharmacist from UNITED STATES on Mar 28, 2007. Female patient, 76 years of age, weighting 172.0 lb, was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting. ZETIA dosage: unknown. During the same period patient was treated with LISINOPRIL, OMEPRAZOLE, INSULIN, METFORMIN, HYDROXYUREA. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Jan 23, 2006. Female patient, 71 years of age, weighting 222.0 lb, was diagnosed with blood cholesterol increased, hyperlipidaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased. ZETIA dosage: 10 MG/HS/PO. During the same period patient was treated with CELEBREX, LIPITOR, SYNTHROID, CLONAZEPAM, ESTROPIPATE. Patient recovered.

ZETIA problem was reported by a Pharmacist from UNITED STATES on Jan 12, 2006. Female patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ZETIA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Jan 11, 2006. Female patient was diagnosed with low density lipoprotein increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ZETIA dosage: unknown. During the same period patient was treated with PRAVACHOL. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Dec 19, 2005. Male patient, 65 years of age, weighting 220.0 lb, was diagnosed with blood cholesterol increased, hyperlipidaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ZETIA dosage: 10 MG/DAILY/PO. During the same period patient was treated with PRILOSEC, SYNTHROID, VOLTAREN, ASPIRIN. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Dec 14, 2006. Female patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: 10 MG/DAILY/PO. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Dec 06, 2005. Male patient, 30 years of age, was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: 10 MG/PO. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Dec 06, 2005. Male patient, 82 years of age, was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: unknown. During the same period patient was treated with ASPIRIN. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Dec 01, 2005. Male patient, 42 years of age, weighting 175.0 lb, was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: rash. ZETIA dosage: 10 MG/DAILY/PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZETIA problem on Nov 30, 2005. Male patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: angioedema. ZETIA dosage: 10 MG/PO. During the same period patient was treated with CLARITIN. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Nov 15, 2005. Male patient was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ZETIA problem on Nov 09, 2005. Male patient was diagnosed with hypercholesterolaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: 10MG, UNK; PO. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Nov 03, 2005. Male patient, 51 years of age, weighting 216.0 lb, was diagnosed with hyperlipidaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: anxiety, rhabdomyolysis. ZETIA dosage: 10MG/DAILY;PO. During the same period patient was treated with ADDERALL, ECOTRIN, EFFEXOR, NEXIUM, SEROQUEL, TOPROL, TRICOR. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Nov 03, 2005. Female patient was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: 10MG, DAILY; PO. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Oct 27, 2005. Female patient, 88 years of age, weighting 110.0 lb, was diagnosed with hyperlipidaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: 10MG, DAILY; PO, 10MG, DAILY; PO. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Jan 23, 2006. Female patient, 44 years of age, was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: diarrhoea. ZETIA dosage: 10MG, DAILY; PO. During the same period patient was treated with ACIPHEX, ZESTRIL. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on July 31, 2006. Male patient, 47 years of age, weighting 186.0 lb, was diagnosed with hypercholesterolaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: 10MG, DAILY; PO. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported ZETIA problem on Dec 06, 2005. Female patient, 64 years of age, weighting 254.0 lb, was diagnosed with hyperlipidaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: swelling face, swollen tongue. ZETIA dosage: 10MG, DAILY; PO. During the same period patient was treated with ALLEGRA, FLEXERIL, FOLPLEX, GLIPIZIDE, LIPITOR, LOZOL, NASONEX, NEXIUM. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Oct 18, 2006. Female patient was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ZETIA dosage: 10MG, DAILY; PO. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Oct 05, 2006. Male patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: rash, rhabdomyolysis. ZETIA dosage: 10MG, DAILY; PO. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Oct 04, 2006. Female patient, 80 years of age, was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. ZETIA dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZETIA problem on Aug 15, 2006. Female patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: laboratory test abnormal, overdose. ZETIA dosage: 80 MG/HS/PO. During the same period patient was treated with MEVACOR, WARFARIN. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Sept 26, 2006. Female patient was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: 10MG, DAILY, PO. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Sept 25, 2006. Female patient was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: 10MG, DAILY; PO. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Sept 18, 2006. Male patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: 10MG, DAILY; PO. Patient recovered.

Pharmacist from UNITED STATES reported ZETIA problem on Mar 30, 2006. Male patient, 45 years of age, was diagnosed with hypercholesterolaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: unknown. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Mar 23, 2006. Female patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ZETIA dosage: 10 MG/DAILY/PO. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Mar 07, 2006. Female patient, 74 years of age, was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. ZETIA dosage: 10 MG/DAILY/PO. During the same period patient was treated with TYLENOL, ZESTRIL, ASPIRIN, ATENOLOL. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Feb 28, 2006. Female patient was diagnosed with blood cholesterol and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: 10 MG/DAILY/PO. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Feb 28, 2006. Male patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. ZETIA dosage: unknown. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2006. Male patient, 45 years of age, was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ZETIA dosage: 10 MG/DAILY/PO. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Feb 13, 2006. Male patient, 65 years of age, was diagnosed with hypercholesterolaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: swelling face. ZETIA dosage: unknown. During the same period patient was treated with ECOTRIN, LASIX. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Feb 07, 2006. Male patient was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: jaundice, pancreatitis. ZETIA dosage: 10 MG/DAILY/PO. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Feb 07, 2006. Female patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: unevaluable event. ZETIA dosage: unknown. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Feb 01, 2006. Female patient was diagnosed with blood cholesterol and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: chest pain. ZETIA dosage: 10 MG/DAILY/PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZETIA problem on Mar 14, 2007. Male patient, 78 years of age, was diagnosed with blood cholesterol increased, diabetes mellitus and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, haemorrhage, myopathy, myositis. ZETIA dosage: 10 MG/UNK/PO. During the same period patient was treated with LIPITOR, WARFARIN, LANTUS, HUMALOG. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Sept 18, 2006. Female patient was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: 10 MG/DAILY/PO. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Sept 14, 2006. Male patient, 45 years of age, was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ZETIA dosage: 10 MG/DAILY/PO. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Sept 08, 2006. Female patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ZETIA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Sept 06, 2006. Male patient was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ZETIA dosage: 10 MG/DAILY/PO. During the same period patient was treated with CRESTOR. Patient recovered.

ZETIA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2006. Female patient, 60 years of age, was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: hepatitis. ZETIA dosage: 10 MG/DAILY/PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZETIA problem on Aug 28, 2006. Female patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: adverse event, no adverse effect, overdose. ZETIA dosage: 20 MG/DAILY/PO. During the same period patient was treated with LIPITOR. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Aug 24, 2006. Male patient, 79 years of age, was diagnosed with blood cholesterol and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: myalgia. ZETIA dosage: 10 MG/DAILY/PO. During the same period patient was treated with COUMADIN, DIOVAN, GLUCOPHAGE, GLUCOTROL, PRAVACHOL, PREVACID. Patient was hospitalized and became disabled. Patient recovered.

Health Professional from UNITED STATES reported ZETIA problem on Aug 23, 2006. Female patient, 74 years of age, was diagnosed with blood cholesterol abnormal and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: myalgia. ZETIA dosage: unknown. During the same period patient was treated with NEXIUM, ATENOLOL. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Aug 18, 2006. Female patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: cholelithiasis. ZETIA dosage: 10 MG/PO. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Aug 18, 2006. Male patient was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: cholelithiasis. ZETIA dosage: 10 MG/PO. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2006. Female patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: unknown. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on July 10, 2006. Female patient, 78 years of age, weighting 147.0 lb, was diagnosed with hyperlipidaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: cholecystitis, cholelithiasis. ZETIA dosage: 10 MG/DAILY/PO. During the same period patient was treated with ACTONEL, DETROL, LEXAPRO, PLETAL, PREMARIN, PRILOSEC, SYNTHROID. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on June 28, 2006. Female patient, 77 years of age, was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ZETIA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on June 23, 2006. Male patient, 63 years of age, weighting 220.0 lb, was diagnosed with dyslipidaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: dysphonia, swollen tongue. ZETIA dosage: 10 MG/DAILY/PO. During the same period patient was treated with PRAVACHOL, ADALAT, FLOMAX, ASPIRIN, BENZONATATE. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Pharmacist from UNITED STATES on June 07, 2006. Female patient, 60 years of age, was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased. ZETIA dosage: 10 MG DAILY PO. During the same period patient was treated with HYDRODIURIL, VASOTEC, ASPIRIN, ATENOLOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZETIA problem on May 19, 2006. Female patient, 63 years of age, was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: chest pain, cholecystitis, cholelithiasis, pancreatitis, vomiting. ZETIA dosage: 10 MG/DAILY/PO. During the same period patient was treated with BENICAR, HYDRODIURIL. Patient was hospitalized and became disabled. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on May 10, 2006. Female patient, 64 years of age, was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: arthralgia, confusional state, constipation, gastrooesophageal reflux disease, hepatitis, menopausal symptoms, mental status changes, osteoarthritis, pain in extremity. ZETIA dosage: 10 MG/DAILY/PO. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on May 02, 2006. Female patient, 75 years of age, was diagnosed with hypercholesterolaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, high density lipoprotein decreased, low density lipoprotein increased. ZETIA dosage: unknown. During the same period patient was treated with FOSAMAX, HYDRODIURIL, PRAVACHOL, VASOTEC, ZANTAC, ZOLOFT, ASCORBIC ACID, NITROGLYCERIN. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Apr 17, 2006. Male patient was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ZETIA dosage: 10 MG/DAILY/PO. During the same period patient was treated with CYCLOSPORINE. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Apr 07, 2006. Female patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: 10 MG/PO. Patient recovered.

ZETIA problem was reported by a Health Professional from UNITED STATES on Aug 17, 2006. Male patient was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: 10 MG/DAILY/PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ZETIA problem on Aug 02, 2006. Female patient, 69 years of age, was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: internal hernia, pancreatitis. ZETIA dosage: 10 MG/PO. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Aug 07, 2006. Female patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ZETIA dosage: 10 MG/DAILY/PO. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Aug 07, 2006. Male patient, 67 years of age, was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ZETIA dosage: 10 MG/DAILY/PO. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on Aug 03, 2006. Male patient was diagnosed with hypercholesterolaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: fatigue, myalgia. ZETIA dosage: unknown. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Aug 01, 2006. Male patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. ZETIA dosage: unknown. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on July 26, 2006. Female patient, 75 years of age, was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: urticaria. ZETIA dosage: 10 MG/DAILY/PO. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on July 25, 2006. Female patient was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: coagulopathy, pancreatitis. ZETIA dosage: unknown. Patient recovered.

ZETIA problem was reported by a Physician from UNITED STATES on July 07, 2006. Female patient, 77 years of age, weighting 170.0 lb, was diagnosed with hyperlipidaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: blood urea increased, diabetes mellitus inadequate control, neutrophilia, normochromic normocytic anaemia, thrombocytopenia. ZETIA dosage: 10 MG/DAILY/PO. During the same period patient was treated with GLUCOPHAGE, LANTUS, LIPITOR, TOPROL, GLYBURIDE. Patient was hospitalized and became disabled. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on July 12, 2006. Male patient, 45 years of age, was diagnosed with hypercholesterolaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. ZETIA dosage: 10 MG/DAILY/PO. During the same period patient was treated with HYDRODIURIL, METOPROLOL SUCCINATE. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Health Professional from UNITED STATES on Mar 20, 2007. Male patient, 72 years of age, was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: flank pain, pancreatitis. ZETIA dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from NETHERLANDS reported ZETIA problem on Mar 27, 2007. Male patient, 58 years of age, was diagnosed with hypercholesterolaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: muscular weakness, tendon rupture. ZETIA dosage: unknown. During the same period patient was treated with FUROSEMIDE, VALSARTAN AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Health Professional from UNITED STATES on Mar 29, 2007. Female patient, 36 years of age, was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, dizziness, muscular weakness. ZETIA dosage: unknown. During the same period patient was treated with ASPIRIN, ALEVE. Patient recovered.

Physician from UNITED STATES reported ZETIA problem on Mar 12, 2007. Male patient was diagnosed with insomnia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: amnesia, fatigue, fracture, road traffic accident, sleep walking. ZETIA dosage: unknown. During the same period patient was treated with FLOMAX, BENICAR, AMBIEN. Patient was hospitalized. Patient recovered.

ZETIA problem was reported by a Physician from FRANCE on Mar 28, 2007. Male patient, 56 years of age, weighting 163.1 lb, was diagnosed with hypercholesterolaemia and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: myalgia, weight decreased. ZETIA dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported ZETIA problem on Nov 30, 2005. Male patient, 68 years of age, weighting 160.9 lb, was diagnosed with blood cholesterol increased and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: dyspnoea. ZETIA dosage: unknown. Patient was hospitalized. Patient recovered.

Showing 1-75 of 500 Next >

Ask Our Patient Community about ZETIA
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine) Pegaptanib Pegvisomant Pemetrexed Pemoline Pentobarbital and carbromal Perflutren lipid microspheres Perindopril Phenergan (promethazine) Pimecrolimus Pioglitazone Placidyl (ethchlorvynol) Plan B (levonorgestrel) Pletal (cilostazol) Poractant alfa Posaconazole Pramlintide Acetate Precedex (dexmedetomidine) Pregabalin Prezista (darunavir) Prialt (ziconotide) Priftin (rifapentine) Prinivil (lisinopril) Procrit (epoetin alfa) ProHance (gadoteridol) Promethazine Propofol Prosom (estazolam) Protonix (pantoprazole) Protopic (tacrolimus) Provigil (modafinil) Prozac (fluoxetine) Prussian blue back to top	Q Quazepam Quetiapine Quinapril Quinupristin R Rabeprazole Radiogardase (prussian blue) Ramelteon Ramipril Ranexa (ranolazine) Ranibizumab Ranolazine Rapamune (sirolimus) Raptiva (efalizumab) Rasagiline Razadyne (galantamine)